Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial Article

Brown, Paul D, Pugh, Stephanie, Laack, Nadia N et al. (2013). Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial . NEURO-ONCOLOGY, 15(10), 1429-1437. 10.1093/neuonc/not114

Open Access ESI Most Cited Paper International Collaboration

cited authors

  • Brown, Paul D; Pugh, Stephanie; Laack, Nadia N; Wefel, Jeffrey S; Khuntia, Deepak; Meyers, Christina; Choucair, Ali; Fox, Sherry; Suh, John H; Roberge, David; Kavadi, Vivek; Bentzen, Soren M; Mehta, Minesh P; Bruner, Deborah Watkins

sustainable development goals

authors

publication date

  • October 1, 2013

webpage

published in

keywords

  • CLINICAL-TRIALS
  • Clinical Neurology
  • Life Sciences & Biomedicine
  • MODERATE VASCULAR DEMENTIA
  • NEUROCOGNITIVE FUNCTION
  • Neurosciences & Neurology
  • Oncology
  • PHASE-II
  • PROGRESSION
  • QUALITY-OF-LIFE
  • RADIATION-THERAPY
  • RECEPTOR-MEDIATED NEUROTOXICITY
  • SURVIVAL
  • Science & Technology
  • TUMOR PATIENTS
  • brain metastases
  • cognition
  • memantine
  • neuroprotective agents
  • radiotherapy

Digital Object Identifier (DOI)

publisher

  • OXFORD UNIV PRESS INC

start page

  • 1429

end page

  • 1437

volume

  • 15

issue

  • 10